Hairy cell leukemia with CCND1/IGH fusion gene and BRAF V600E mutation

Zaid Abdel Rahman1, Firas Muwalla2, Liuyan Jiang3

  • 1Division of Hematology and Medical Oncology, Mayo Clinic, 4500 San Pablo Rd S, Jacksonville, FL, United States.

Insights

This study reports a rare case of Hairy Cell Leukemia (HCL) with co-occurring genetic mutations, CCND1/IGH and BRAF V600E. This unique presentation may indicate a distinct HCL subtype.

Area of Science:

  • Hematology
  • Oncology
  • Genetics

Background:

  • Hairy Cell Leukemia (HCL) is a rare chronic lymphoid leukemia.
  • Diagnosis typically relies on specific immunophenotypic markers and genetic mutations.
  • Co-occurrence of certain genetic alterations can complicate diagnosis and classification.

Purpose of the Study:

  • To report a rare case of HCL with concurrent CCND1/IGH translocation and BRAF V600E mutation.
  • To discuss the diagnostic implications of this co-occurrence.
  • To explore the potential for a new HCL subtype.

Main Methods:

  • Peripheral blood and bone marrow examination.
  • Flow cytometry for immunophenotyping.
  • Fluorescence in situ hybridization (FISH) for chromosomal translocations.
  • Polymerase chain reaction (PCR) for mutation analysis.
  • Cyclin-D1, Annexin-A1, and TRAP staining.

Main Results:

  • Patient presented with pancytopenia and abnormal lymphocytes.
  • Flow cytometry revealed monoclonal B-cells with a specific marker profile.
  • FISH detected t(11;14) translocation.
  • PCR confirmed BRAF V600E mutation.
  • Immunohistochemistry positive for cyclin-D1, Annexin-A1, and TRAP.
  • Diagnosis of HCL favored due to combined findings.
  • Patient achieved complete remission (CR) with cladribine therapy.

Conclusions:

  • The co-occurrence of CCND1/IGH and BRAF V600E in HCL is rare.
  • This genetic profile may represent a distinct subtype of HCL.
  • Further research is warranted to characterize this potential new subtype.